Article information
Full text is only aviable in PDF
References
[1.]
S.A. Spinler, B.S. Globus, J.Z. Raymond, M.L. Lancefield.
Indapamide-associated Stevens-Johnson syndrome.
Cutis, 50 (1992), pp. 200-202
[2.]
J. Partanen, S. Pohjola-Sintonen, M. Mäkijärvi.
Toxic epidermal necrolysis due to indapamide.
Arch Dermatol, 29 (1993), pp. 793
[3.]
R.J. Black, P. Murphy, T.J. Robinson, K.W. Scout.
Toxic epidermal necrolysis associated with indapamide.
Br Med J, 301 (1990), pp. 1280-1281
[4.]
B. Rzany, M. Mockenhaupt, S. Baur.
Epidemiology of erythema exudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry.
J Clin Epidemiol, 49 (1996), pp. 769-773
[5.]
C. Laguna, B. Martín, A. Torrijos, M.L. García-Melgares, I. Febrer.
Síndrome de Stevens-Johnson y necrólisis epidérmica tóxica: experiencia clínica y revisión de la literatura especializada.
Actas Dermosifiliogr, 97 (2006), pp. 177-185
[6.]
D. García Fernández, V. García-Patós Briones, A. Castell Rodellas.
Síndrome de Stevens-Johnson/necrólisis epidérmica tóxica.
Piel, 16 (2001), pp. 444-457
[7.]
M. Yuste, J. Sánchez-Estella, J.C. Santos, M.T. Alonso, M.T. Bordel, J.L. Gutiérrez, et al.
Síndrome de Stevens-Johnson/necrólisis epidérmica tóxica tratada con inmunoglobulinas intravenosas.
Actas Dermosifiliogr, 96 (2005), pp. 589-592
[8.]
J.M. Calkin, H.I. Maibach.
Delayed hypersensitivity drug reactions diagnosed by patch testing.
Contact Dermatitis, 29 (1993), pp. 223-233
[9.]
P. Wolkenstein, O. Chosidow, M.L. Fléchet, O. Robbiola, M. Paul, L. Dumé, et al.
Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
Contact Dermatitis, 35 (1996), pp. 324-326
Copyright © 2008. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
